Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...

Piper Sandler analyst Michael Lavery has raised the firm’s price target on Celsius Holdings, Inc. (NASDAQ:CELH) to $45 from ...

Cantor Fitzgerald analysts reaffirmed their price target of $71 and Overweight rating on CVS Health Corporation (NYSE:CVS) on ...

On Friday, Piper Sandler analysts reiterated their Overweight rating for BridgeBio Pharma (NASDAQ:BBIO) stock, maintaining a price target of $63.00. The stock has shown remarkable momentum ...

InvestingPro analysis reveals the company maintains a "GREAT" overall financial ... Barclays downgraded Centene's stock from Overweight to Equalweight, citing concerns in the Part D and Affordable ...

Obesity — like most other medical conditions — requires an “arsenal” of treatments, rather than a one-size-fits-all approach.

Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while ...

Morgan Stanley maintains an 'overweight' rating on Trent with a target price of Rs 6,359. The brokerage highlights Trent's ...

Deep-pocketed investors have adopted a bearish approach towards Cisco Systems CSCO, and it's something market players shouldn ...

Enrollment in a patient-delivered intervention allowed adults with overweight or obesity to better maintain weight loss than ...

While tariffs may not be as high as was originally proposed, policy uncertainty remains, which will likely weaken US and ...

People on low-calorie diets scored higher for symptoms of depression, compared with those not dieting, researchers reported.